Covered recipient · General Payments record
THOMAS KEMMERLY
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$7,266.18
- Reported across 432 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $640.17 | 36 |
| Education | $13.76 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $277.59 | 12 |
| ABBVIE INC. | $275.36 | 20 |
| Janssen Biotech, Inc. | $48.03 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $33.68 | 2 |
| Gilead Sciences, Inc. | $19.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.94 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050868 | CMS |
| ABBVIE INC. | $5.96 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050870 | CMS |
| ABBVIE INC. | $3.02 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050872 | CMS |
| ABBVIE INC. | $4.94 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050874 | CMS |
| ABBVIE INC. | $9.78 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050876 | CMS |
| ABBVIE INC. | $16.98 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050878 | CMS |
| ABBVIE INC. | $9.08 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050880 | CMS |
| ABBVIE INC. | $15.11 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050882 | CMS |
| ABBVIE INC. | $19.13 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050884 | CMS |
| ABBVIE INC. | $2.78 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050886 | CMS |
| ABBVIE INC. | $21.40 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050888 | CMS |
| ABBVIE INC. | $25.57 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050890 | CMS |
| ABBVIE INC. | $4.08 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050892 | CMS |
| ABBVIE INC. | $22.13 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050894 | CMS |
| ABBVIE INC. | $23.91 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050896 | CMS |
| ABBVIE INC. | $20.37 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050898 | CMS |
| ABBVIE INC. | $3.40 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050900 | CMS |
| ABBVIE INC. | $20.23 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050902 | CMS |
| ABBVIE INC. | $19.38 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050904 | CMS |
| ABBVIE INC. | $4.17 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104050906 | CMS |
| Gilead Sciences, Inc. | $19.27 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133791599 | CMS |
| Janssen Biotech, Inc. | $26.72 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078312808 | CMS |
| Janssen Biotech, Inc. | $21.31 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078313038 | CMS |
| PFIZER INC. | $19.24 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131192061 | CMS |
| PFIZER INC. | $19.24 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131192065 | CMS |
| PFIZER INC. | $19.24 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131192068 | CMS |
| PFIZER INC. | $29.37 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131289731 | CMS |
| PFIZER INC. | $7.11 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131715152 | CMS |
| PFIZER INC. | $23.62 | 06/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131642873 | CMS |
| PFIZER INC. | $27.25 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131751196 | CMS |
| PFIZER INC. | $25.50 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131789205 | CMS |
| PFIZER INC. | $27.25 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131768395 | CMS |
| PFIZER INC. | $26.35 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131984939 | CMS |
| PFIZER INC. | $26.88 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131945740 | CMS |
| PFIZER INC. | $26.54 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132114441 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.76 | 03/21/2024 | Education | Undisputed | 01/23/2026 | 1137598537 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.92 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137598541 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.